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ttp://dx.doi.org/10.1016/j.ajpath.2015.05.015Intrauterine inﬂammation is recognized as a key mediator of both normal and preterm birth but is also
associated with neonatal neurological injury. Lipopolysaccharide (LPS) is often used to stimulate in-
ﬂammatory pathways in animal models of infection/inﬂammation-induced preterm labor; however,
inconsistencies in maternal and neonatal responses to LPS are frequently reported. We hypothesized
that LPS serotype-speciﬁc responses may account for a portion of these inconsistencies. Four different
Escherichia coli LPS serotypes (O111:B4, O55:B5, O127:B8, and O128:B12) were administered to CD1
mice via intrauterine injection at gestational day 16. Although control animals delivered at term
60  15 hours postinjection (p.i.), those administered with O111:B4 delivered 7  2 hours p.i., O55:B5
delivered 10  3 hours p.i., O127:B8 delivered 16  10 hours p.i., and O128:B12 delivered 17  2
hours p.i. (means  SD). A correlation between the onset of preterm labor and myometrial activation of
the inﬂammatory transcription factor, activator protein 1, but not NF-kB was observed. Speciﬁc LPS
serotypes induced differential activation of downstream contractile and inﬂammatory pathways in
myometrium and neonatal pup brain. Our ﬁndings demonstrate functional disparity in inﬂammatory
pathway activation in response to differing LPS serotypes. Selective use of LPS serotypes may represent
a useful tool for targeting speciﬁc inﬂammatory response mechanisms in these models. (Am J Pathol
2015, 185: 2390e2401; http://dx.doi.org/10.1016/j.ajpath.2015.05.015)Supported by the Wellcome Trust grant DSRR_P24225 (S.N.W., D.P.,
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P.R.B.), and the Medical Research Council Career Development Award
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Disclosures: None declared.Preterm birth and its associated complications are now the
leading cause of death among children <5 years.1 A lack
of knowledge of the basic molecular mechanisms
orchestrating the onset of preterm and term labor has
prevented advancements being made in early diagnosis
and has inhibited the design of effective treatments.
Evidence from both human and animal studies indicates
that activation of inﬂammatory pathways in gestational
tissues is a shared mechanism common to both normal
and preterm birth.2,3 Intrauterine inﬂammation is also
associated with fetal brain injury, which may lead to long-
term neurological disorders, such as cerebral palsy.4,5 An
increasing body of evidence supports the involvement ofstigative Pathology.
.inﬂammation also, in the absence of overt infection, in
preterm birth.2 A key mediator of the inﬂammatory
response in gestational tissues at the time of labor is NF-k
light chain enhancer of activated B cells (NF-kB); how-
ever, data have also implicated activator protein 1 (AP-1)
and CCAAT/enhancer-binding proteins (C/EBPs) in the
LPS Serotypes in Murine Preterm Laborregulation of inﬂammatory pathways associated with the
onset of labor.6e9
In various animal models of preterm labor (PTL), the
Gram-negative bacterial cell wall component, lipopolysac-
charide (LPS), is administered systemically to mimic bac-
terial infection during pregnancy or locally via an
intrauterine injection to reﬂect ascending vaginal infection
and/or chorioamnionitis.10e21 Recognition of the LPS
molecule by Toll-like receptors (TLRs), expressed on the
surface of intrauterine cells,15,21 activates an inﬂammatory
cascade that drives proinﬂammatory cytokine production
and, subsequently, the release of prostaglandins, cytokines,
and chemokines promoting cervical ripening, uterine acti-
vation, and contractility.14,22 Although the inﬂammatory
response to LPS appears to be consistently achieved in
mouse models of preterm birth, signiﬁcant variation in the
timing of preterm birth and neonatal survival outcomes is
often reported, only a proportion of which can be attributed
to differences in experimental design (eg, gestation age at
time of injection, site of administration, animal species/
strain, and LPS dose).
The LPS molecule is composed of a complex glycolipid
containing a lipid A moiety (phosphorylated glucosamine
disaccharide with multiple fatty acid chains), an oligosac-
charide core, and an extending glycan polymer referred to as
the O-antigen. The sugar composition of this polysaccharide
side chain determines the serological speciﬁcity of the
molecule, whereas the lipid A group typically confers
toxicity.23 Previous studies in rat models of hypothermia
and albumin extravasation have reported functional differ-
ences caused by LPS serotype speciﬁcity.24,25 Treatment of
fever with the selective cyclooxygenase (COX)-2 inhibitor,
4-[5-(4-chlorophenyl)-3-(triﬂoromethyl)-1H-pyrazol-l-yl]
benzenesulfonamide (SC-58236), is effective in the initial
phase of animals administered with Escherichia coli
O55:B5 LPS, but not those administered with E. coli
O111:B4 LPS.26,27 Moreover, different E. coli LPS sero-
types can be associated with deﬁned clinical syndromes of
enteric/diarrheal disease.28,29 Collectively, these data indi-
cate serotype-speciﬁc activation of inﬂammatory pathways
that translates into variable phenotypic responses. In the
context of animal models of infection/inﬂammation-induced
PTL, this could involve differential activation of the key
inﬂammation-mediated pathways preceding labor, thus
leading to differential maternal and neonatal outcomes.
Therefore, we hypothesized that LPS serotypes elicit spe-
ciﬁc maternal and neonatal innate immune responses that
involve differential activation of inﬂammatory pathways.
By using four different E. coli LPS serotypes (O111:B4,
O55:B5, O127:B8, and O128:B12), we demonstrate func-
tional disparity in LPS serotype activation of inﬂammatory
pathways in the uterus and the pup brain. Our results indi-
cate that the use of speciﬁc LPS serotypes may provide a
useful tool for the selective activation of speciﬁc inﬂam-
matory response mechanisms in animal models of preterm
birth.The American Journal of Pathology - ajp.amjpathol.orgMaterials and Methods
Murine Studies and Ethics Statement
Animal studies were performed under UK Home Ofﬁce
License 70/6906, in accordance with the guidance to Ani-
mals Scientiﬁc Procedures Act of 1986, and with approval
of the Imperial College London and University College
London (London, UK) Ethical Review Committees. CD1
outbred virgin females were timed mated, and the presence
of a copulatory plug was classiﬁed as embryonic day 0 (E0)
of gestation. Mice were housed in open cages at
21C  1C with ad libitum access to standard rodent food
and water and were exposed to a 12:12 light-dark cycle
regimen. Unless otherwise stated, ﬁve biological replicates
were collected for all experimental groups.
Murine Model of Inﬂammation-Induced PTL
Pregnant (E16) female dams were administered a s.c. in-
jection of 2.5 mg/kg morphine 20 minutes before surgery.
Animals were anesthetized by isoﬂurane, and a laparotomy
was performed as previously described.9,30,31 Brieﬂy, both
uterine horns were exteriorized and the number of live fe-
tuses per horn was recorded. An intrauterine injection of 20
mg [25 mL total volume in phosphate-buffered saline (PBS)]
of either E. coli LPS serotype O111:B4, O55:B5, O127:B8,
or O128:B12 (Sigma Aldrich, Gillingham, UK) or sterile
PBS was injected into the upper right uterine horn between
the ﬁrst and second sacs. Biochemical characteristics of the
LPS serotypes were consistent [phenol extracted; protein
content, 3%; solubility, 4.9 to 5.1 mg/mL; endotoxin
level, 500,000 endotoxin units (EU)/mg]. Animals were
continuously monitored after surgery remotely via an
infrared closed circuit TV camera system during recovery
until tissue collection or the onset of spontaneous delivery.
The onset of labor was deﬁned as delivery of the ﬁrst pup.
Tissue Collection
For tissue collection, mice were anesthetized and sacriﬁced
by cervical dislocation. A laparotomy was performed, uteri
were immediately incised in the longitudinal direction, and
pups were isolated and sacriﬁced by decapitation. Right and
left horns of the uterus were snap frozen separately after
removal of gestational membranes, placentas, and vascula-
ture. Myometrium samples from the right uterine horns were
used for mRNA and protein analyses. After decapitation,
whole pup brains were isolated and snap frozen. Tissue was
stored at 80C until extraction. Before culling, pup
viability was qualitatively assessed using a scoring system
as follows: 3, pups displaying full body spontaneous
movement when removed from the myometrium or amni-
otic sac; 2, pups with partial body movement (ie, lower half
or full body movement when gently prodded with forceps);
1, pups exhibiting partial body movement or movement of2391
Migale et allimbs only in response to forceful prodding or squeezing of
a limb with forceps’ and 0, pups with no response when
forcefully prodded or limbs squeezed.
Protein Extraction and Western Blot Analysis
Myometrial and whole pup brain protein lysates were prepared
by grinding tissue under liquid nitrogen in a mortar and pestle,
then homogenizing in a modiﬁed radioimmunoprecipitation
assay buffer (1% Triton X-100, 1% 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate, 0.1% SDS, 1% deox-
ycholic acid, 50 mmol/L NaF, 1 mmol/L orthovanadate,
protease inhibitor cocktail, 25 mmol/L Tris [pH 7.4], and 150
mmol/L NaCl) at a ratio of 1 mL buffer:100 mg wet weight
tissue. Protein lysates were centrifuged at 13,000  g, and
protein concentration was determined via a Bradford assay
(Bio-Rad, Hemel Hempstead, Hertfordshire, UK). Extracted
proteins (20 mg per sample) were separated by SDS-PAGE and
transferred to a polyvinylidene diﬂuoride membrane (GE
Healthcare, Little Chalfont, UK) at 100 V (constant voltage) at
4C. Membranes were blocked with 5% skim milk in Tris-
buffered saline (TBS) supplemented with 0.01% Tween 20
(TBST) for 1 hour and then incubated overnight at 4C with
primary antibodies raised against phosphorylated (p) NF-kB:
p65 Ser536 (1:1000 in TBS; catalog number 3031; Cell
Signaling Technology, Hitchin, Herts, UK), p-c-Jun Ser73
(1:1000 in TBST containing 1% milk; catalog number 9164;
Cell Signaling Technology); CX43 (1:1000 in TBST contain-
ing 1% milk; catalog number 3512; Cell Signaling Technol-
ogy); p-C/EBPb Thr235 (1:1000 in 1% bovine serum albumin;
catalog number 3084; Cell Signaling Technology); COX-2
(1:2000 in TBST containing 5% milk; catalog number sc-
1745; Santa Cruz Biotechnology, Dallas, TX); and IL-1b
(1:1000 in TBST containing 1%milk; catalog number AF-401-
NA; R&D Systems, Abingdon, UK). After primary antibody
incubation, membranes were washed six times (5 minutes
each) with TBST and subsequently incubated with the appro-
priate horseradish peroxidaseeconjugated secondary antibody
for 1 hour at room temperature (1:2000; Cell Signaling Tech-
nology) before being washed again with TBST. Detection
of immunoreactive bands was performed by enhancedTable 1 Primer Sequences Used for Real-Time Quantitative RT-PCR
Gene
Primer sequence
Forward
Ptgs2 (Cox2) 50-CTGACCCCCAAGGCTCAAAT-3
Mmp3 50-GCTGTCTTTGAAGCATTTGGGT
Mmp10 50-CACCCTCAGGGACCAACTTA-3
Cxcl2/Il8 50-GCCCAGACAGAAGTCATAGCC-
Il6 50-TCCTCTCTGCAAGAGACTTCC-
Il1b 50-AGCTTCCTTGTGCAAGTGTCT-
Tnfa 50-ATGGCCTCCCTCTCATCAGT-3
Gja1 (Cx43) 50-GCCCGAACTCTCCTTTTCCT-3
Nos2 (iNOS) 50-GTGTTCCACCAGGAGATGTTG-
Nos3 50-GCTCCCAACTGGACCATCTC-3
2392chemiluminescence (ECL; GE Healthcare) using the Image-
Quant LAS 4000 Imager (GE Healthcare). Membranes were
stripped with 0.2 mol/L NaOH for 5 minutes at room temper-
ature, washed in TBST, and reprobed with b-actin (1:40,000;
Sigma Aldrich) as a loading control. Densitometric analysis
was conducted using ImageQuant TL (GE Healthcare).
RNA Isolation and Real-Time Quantitative RT-PCR
mRNA was isolated from ground myometrial and whole pup
brain tissue using the Nucleospin miRNA kit (Macherey-
Nagel, Düren, Germany) following the manufacturer’s in-
structions. RNA concentration and integrity were measured
with a NanoDrop 1000 spectrophotometer (ThermoScientiﬁc,
Waltham, MA) and an Agilent 2100 bioanalyzer (Agilent
Technologies, Santa Clara, CA). cDNA synthesis was per-
formed on 2 mg RNA using M-MLV Reverse Transcriptase
(Sigma-Aldrich). RNA was incubated with 1 mL of 0.5 mg/mL
Oligo(dT)23 Primers Anchored (Sigma-Aldrich) and 1 mL of
10mmol/L dNTPmix (Sigma-Aldrich) for 10minutes at 70C
and then transferred onto ice. Master mix (10 mL) containing
6.5 mL of nuclease-free water, 2 mL of M-MLV Reverse
Transcriptase Buffer, 0.5 mL of human ribonuclease inhibitor
(40,000 U/mL; Sigma-Aldrich), and 1 mL of 200 U/mL M-
MLV Reverse Transcriptase was added to each RNA sample
and incubated at room temperature for 15 minutes, then at
37C for 50 minutes, and ﬁnally at 85C for 10 minutes to
inactivate the enzyme. Isolated cDNA was stored at 20C.
For each target gene, a gene-speciﬁc primer set of 8 to 22 bp
was designed using the National Center for Biotechnology
Information Database (http://www.ncbi.nlm.nih.gov/tools/
primer-blast, last accessed April 29, 2015) with optimal Tm
of 60C (Table 1). Both forward and reverse primers were
designed to span exon-exon junctions.
Real-time quantitative RT-PCR was performed in 384-well
plates in duplicate using a total volume of 10 mL containing
2.6-mL nuclease-free water, 0.1 mL ROX reference dye
(Sigma-Aldrich), 0.15 mL forward primer (20 mmol/L), 0.15
mL reverse primer (20 mmol/L), 5 mL SYBR Green JumpStart
Taq ReadyMix (Sigma-Aldrich), and 2 mL of cDNA. Re-
actions were run on an ABI 7900HT (Applied BiosystemsReverse
0 50-AAGTCCACTCCATGGCCCAG-30
T-30 50-CACAGGATGCCTTCCTTGGAT-30
0 50-TAGCTGGGCTTGTGGAGAAC-30
30 50-AGGCTCCTCCTTTCCAGGTC-30
30 50-GGTCTGTTGGGAGTGGTATCC-30
30 50-GCAGCCCTTCATCTTTTGGG-30
0 50-CTTGGTGGTTTGCTACGACG-30
0 50-CATGTCTGGGCACCTCTCTTT-30
30 50-CTCCTGCCCACTGAGTTCGTC-30
0 50-TCTTGCACGTAGGTCTTGGG-30
ajp.amjpathol.org - The American Journal of Pathology
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Figure 1 Speciﬁc Escherichia coli lipopolysaccharide (LPS) serotypes
induce differential maternal and neonatal outcomes in a murine model of
preterm labor. A: The mean time of delivery of control dams administered an
upper intrauterine injection of phosphate-buffered saline (PBS) is 60  4
hours postinjection (p.i.), whereas those administered O111:B4 deliver 7
1 hours p.i., O55:B5 deliver 10 1 hours p.i., O127:B8 deliver 16 4 hours
p.i., and O128:B12 deliver 171 hours p.i. B: Pup viability rates at 6 hours
postinjection are 100% for PBS and O128:B12-treated dams; however, in
the case of O111:B4, all pups die at 6 hours. Pup viabilities for O55:B5 and
O127:B8 serotypes are 80% and 95%, respectively. ***P < 0.001 indicates
signiﬁcant differences compared with PBS-injected control dams; yP< 0.05
indicates signiﬁcant differences within the LPS treatment group (one-way
analysis of variance with Tukey’s post hoc analysis). nZ 5 (A and B).
LPS Serotypes in Murine Preterm LaborFoster City, CA) as follows: 2 minutes at 94C and 40 cycles
of 15 seconds at 94C, 60 seconds at 60C, and 60 seconds at
72C; the dissociation curve was 15 seconds at 95C, 1 minute
at 60C, and 15 seconds at 95C. Data were processed using
ABI 7900HT SDS version 2.4 software and analyzed with
Excel (Ofﬁce 2010; Microsoft, Redmond, WA). Gene
expression levels for each sample were normalized to the
endogenous reference b-actin mRNA for each well (DCT).
Relative efﬁciencies of gene target and endogenous control
ampliﬁcation were assessed using standard curves generated
for each gene by 10-fold serial dilutions of the same sample
run in duplicate. The comparative CT method was used to
determine differences between LPS- and PBS-treated control
samples. Dissociation curve analysis, conﬁrmed by 2%
agarose gel electrophoresis, was used to verify that a single
gene-speciﬁc product was produced (data not shown).
Statistical Analysis
Each experiment consisted of ﬁve biological replicates, and
results are presented as means SD unless otherwise speciﬁed.
Densitometric values were normalized to b-actin before
undertaking statistical analyses using GraphPad Prism 5.0
(GraphPad Software, San Diego, CA). The statistical sig-
niﬁcance between LPS- and PBS-treated control samples
was assessed using a two-tailed t-test or one-way analysis of
variance (with Tukey’s post hoc test) where appropriate.
P < 0.05 was considered statistically signiﬁcant. For linear
regression, mean levels of p-c-Jun normalized to b-actin for
each serotype at 6 hours after injection were calculated and
regressed against mean time of delivery for each serotype.
The coefﬁcient of determination (r2) of the linear regression
was calculated and reported as a measure of goodness of ﬁt.
Results
E. colieDerived LPS Serotypes Induce Different
Maternal and Neonatal Outcomes in a Murine
Model of PTL
To characterize the effects of different LPS serotypes on
PTL induction and neonatal outcome in mice, pregnant
dams received an upper-intrauterine injection of 20 mg of
E. coliederived LPS serotype O111:B4, O55:B5, O127:B8,
or O128:B12 on E16. Although control dams administered
PBS delivered approximately 60  15 hours postinjection
(p.i.) at term, animals injected with O111:B4 delivered 7  2
hours p.i., O55:B5 delivered 10  3 hours p.i., O127:B8
delivered 16 10 hours p.i., and O128:B12 delivered 17 2
hours p.i. (data are given as means  SD) (Figure 1A). The
percentage of dams who delivered preterm with each serotype
was 100%, where preterm birth was deﬁned as delivery
before 36 hours postinjection. Major differences were also
observed in fetal viability at 6 hours after LPS administration
(Figure 1B). Pup survival rates in dams injected with PBS or
O128:B12 were 100%, with pups displaying a strongThe American Journal of Pathology - ajp.amjpathol.orgresponse to mechanical stimuli. However, in animals injected
with LPS O111:B4, no surviving pups were observed 6 hours
p.i. Pup survival rates for O55:B5 and O127:B8 serotypes
were 80% and 95%, respectively, with pups displaying a
reduced response to mechanical stimuli compared with PBS
control or O128:B12 treated animals.
Activation of Myometrial AP-1 Is Associated with the
Onset of PTL
To investigate transcription factors potentially involved in
modulating inﬂammation preceding myometrial contractile
activation in response to LPS serotype treatment, Western blot
analysis was used to examine the phosphorylation status of
three key inﬂammatory transcription factors (NF-kB, AP-1, and
C/EBPb) in myometrium samples collected from treated and
control animals 6 hours after injection, before delivery
(Figure 2, A and B). Administration of LPS O111:B4 led to a
3.4-fold increase in the phosphorylation of the AP-1 subunit,
p-c-Jun, compared with PBS control [means  SD, 7.9  6.2
arbitrary units (AUs) and 2.3  1.6 AUs, respectively;
P < 0.05]. Induction of p-c-Jun phosphorylation by LPS
O111:B4 was 5.3-fold higher than levels achieved by LPS
O127:B8 (1.5  2.5 AUs, P < 0.05) and 26-fold higher than2393
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Figure 2 Activation of myometrial activator protein 1 (AP-1) is strongly induced by lipopolysaccharide (LPS) O111:B4 and precedes the onset of preterm
labor. Examination of myometrial protein lysates collected 6 hours after intrauterine injection of either phosphate-buffered saline (PBS) or LPS (serotypes
O111:B4, O55:B5, O127:B8, or O128:B12). Results were analyzed by Western blot analysis for the transcriptionally active phosphorylated forms of AP-1 subunit
c-jun (A and B), NF-kB subunit p65 (A and C), and CCAAT/enhancer-binding protein (C/EBPb) isoforms, liver-enriched activating protein (LAP; ﬁrst column)
and liver-enriched inhibitory protein (LIP; second column) (A and D). Densitometric analysis of immunoreactive protein reveals an increase in p-c-Jun (B), but
not p-p65 (C) or C/EBPb isoforms (D), compared with PBS controls. Linear regression of p-c-Jun levels against time to labor shows a correlation between high
levels of myometrial p-c-Jun and rapid onset of preterm labor (E). nZ 5 (E). *P < 0.05, versus PBS-injected control dams; yP < 0.05, within LPS treatment
group (one-way analysis of variance with Tukey’s post hoc analysis). AU, arbitrary unit; CAL, calibrator; p.i., postinjection.
Migale et alLPS O128:B12 (0.3  0.1 AUs, P < 0.05). No difference in
AP-1 activation was observed in animals treated with O55:B5
(3.0  3.0 AUs), O127:B8, or O128:B12 compared with
PBS-injected control dams (2.3 1.6 AUs). Levels of activated
NF-kB in control and treated animals remained largely un-
changed, as assessed by detection of phosphorylated p65
(Figure 2, A and C). Although the levels of C/EBPb activation
between PBS control and LPS-treated animals also
remained unchanged, signiﬁcantly less phosphorylation of
both the transcriptionally active C/EBPb isoform, liver-
enriched activator protein (LAP), and the functional LAP
antagonist, liver-enriched inhibitory protein (LIP), was
observed in the myometrium of dams treated with O127:B8
(LAP, 0.8  0.5 AUs; LIP, 0.7  0.3 AUs) and O128:B12
(LAP, 0.6  0.1 AUs; LIP, 0.5  0.1 AUs) compared with
O111:B4-treated animals (LAP, 1.7 0.7 AUs; LIP, 1.9 1.0
AUs) (Figure 2, A and D). Linear regression analysis showed a
moderate correlation (r2 Z 0.37, P < 0.001) (Figure 2E)
between p-c-Jun levels and labor onset, where higher levels of
p-c-Jun are associated with rapid onset.
E. coli LPS Serotypes Induce Variable Expression of
Proinﬂammatory and Procontractile Genes in Mouse
Myometrium
To investigate the LPS serotype-speciﬁc effects on the
acquisition of a laboring phenotype, real-time quantitative2394RT-PCR was used to analyze the myometrial mRNA
expression of proinﬂammatory and procontractile genes 6
hours after intrauterine injection of vehicle control or LPS
serotypes. Compared with PBS control, an increase in
mRNA of the key labor-associated genes encoding the
prostaglandin synthase enzyme Cox-2 was observed after
LPS O111:B4 (21.1-fold change, P < 0.001), O55:B5
(15.5-fold change, P < 0.001), O127:B8 (20.1-fold change,
P < 0.001), and O128:B12 (6.8-fold change, P < 0.01)
injection (Figure 3A). Furthermore, induction of Cox-2
mRNA was 3.1-fold higher in LPS O111:B4-treated ani-
mals compared with O128:B12 (P < 0.05).
Cx43 mRNA levels were increased twofold after treat-
ment with O127:B8 (P < 0.01) compared with control an-
imals, whereas levels in LPS O55:B5 and O128:B12
remained similar to PBS-injected control mice (Figure 3B).
Injection of LPS O111:B4 induced a 1.7-fold increase in
Cx43 mRNA expression. An increase in tumor necrosis
factor-a (Tnf-a) mRNA levels was induced by all tested
LPS serotypes, with the highest response induced by LPS
O111:B4 (11.3-fold change, P < 0.001) compared with
control (Figure 3C). A similar pattern of Il-1b mRNA in-
duction was observed in response to LPS treatments; how-
ever, statistical signiﬁcance was not reached (Figure 3D).
Clear LPS serotype-speciﬁc activation of Il-6 mRNA was
detected, with LPS O111:B4 eliciting a 52-fold increase
(P < 0.001) compared with PBS control animals, whereasajp.amjpathol.org - The American Journal of Pathology
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Figure 3 Different serotypes of lipopolysaccharide (LPS) induce variable expression of proinﬂammatory and procontractile genes in mouse myometrium.
Dams were sacriﬁced at 6 hours after intrauterine injection, and tissue was harvested for real-time quantitative RT-PCR analysis of procontractile and in-
ﬂammatory genes associated with labor onset, including cyclooxygenase 2 (Cox-2; A), Cx-43 (B), tumor necrosis factor-a Tnf-a (C), Il-1b (D), Il-6 (E), Il-8 (F),
matrix metalloproteinase 3 (Mmp3; G), Mmp10 (H), and inducible nitric oxide synthase (iNOS; I) mRNA. Data are presented relative to b-actin mRNA levels.
nZ 5 (AeI). *P < 0.05, **P < 0.01, and ***P < 0.001, versus phosphate-buffered saline (PBS)einjected control dams; yP < 0.05, yyP < 0.01, within LPS
treatment group (one-way analysis of variance with Tukey’s post hoc analysis).
LPS Serotypes in Murine Preterm LaborO55:B5, O127:B8, and O128:B12 induced a 14-fold
(P < 0.01), 31-fold (P < 0.001), and 12-fold (P < 0.01)
increase compared with control levels (Figure 3E). Levels of
Cxcl2 mRNA, the functional murine homologue of the
human IL8 gene (referred to as Il-8 herein), consistently
increased between 13-fold and 26-fold (P < 0.001) after all
LPS serotype treatments compared with PBS control-treated
dams (Figure 3F).
mRNA levels of the extracellular matrix degradation
enzymes, metalloproteinases Mmp3 and Mmp10, increased
in a LPS serotypeedependent manner. Although all sero-
type treatments promoted Mmp3 mRNA expression
compared with control levels, LPS O111:B4 (6.6-fold in-
crease, P < 0.001) and O127:B8 (8.6-fold change,
P < 0.001) led to signiﬁcantly higher induction than
O55:B5 (2.9-fold) or O128:B12 (3.4-fold) (Figure 3G).
Similarly, levels of Mmp10 mRNA expression signiﬁcantly
increased 6 hours after injection with LPS O111:B4 (5.2-
fold change, P < 0.05) and O127:B8 (3.7-fold change,
P < 0.05), yet no change in Mmp10 mRNA levels wasThe American Journal of Pathology - ajp.amjpathol.orgobserved between control and O55:B5 or O128:B12 treatments
(Figure 3H). mRNA levels of inducible nitric oxide synthase
(iNOS) consistently increased after treatment with LPS
O111:B4 (38.2-fold change, P < 0.001), O55:B5 (21.5-fold
change, P < 0.001), O127:B8 (29.8-fold change, P < 0.001),
and O128:B12 (31.8-fold change, P < 0.001) (Figure 3I).
Characterization of LPS Serotype-Speciﬁc Modulation
of Inﬂammatory and Uterine Activation Associated
Proteins in the Myometrium
By using Western blot analysis, we next assessed the levels of
proteins associated with uterine activation in the myometrium
of animals administered the differing LPS serotypes or PBS
control. To achieve this, dams on E16 were sacriﬁced 6 hours
after intrauterine injection of PBS control or LPS serotypes
O111:B4, O55:B5, O127:B8, or O128:B12, and myometrium
protein lysates were analyzed for the key inﬂammatory
mediator, IL-1b, and the uterine activation associated proteins
COX-2 and CX43. Densitometric analysis of immune-reactive2395
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Figure 4 Changes in levels of proteins associated with uterine activation in the mouse myometrium after different lipopolysaccharide (LPS) serotype
treatments. Protein levels of IL-1b (AeC), cyclooxygenase 2 (COX-2; A and D), and CX-43 (A and E) were examined using Western blot analysis in myometrial
protein lysates collected from pregnant mice 6 hours after phosphate-buffered saline (PBS) or LPS intrauterine injection. Differing protein levels of proeIL-1b
and cleaved IL-1b are detected in samples treated with the various LPS serotypes (B and C). Differing degrees of COX-2 expression are also observed. nZ 5
(AeE). *P < 0.05, **P < 0.01, and ***P < 0.001, versus PBS-injected control dams; yP < 0.05, within LPS treatment group (one-way analysis of variance
with Tukey’s post hoc test). AU, arbitrary unit; CAL, calibrator.
Migale et alprotein revealed that levels of the IL-1b precursor, proeIL-1b
(relative molecular massZ 31,000), signiﬁcantly increased by
LPS O111:B4 compared with PBS-treated animals (2.0  0.9
and 0.2  0.1 AUs, respectively; P < 0.001). In addition, LPS
O111:B4 signiﬁcantly increased the expression of proeIL-1b
compared with O55:B5 (0.8  0.3 AUs, P < 0.05), O127:B8
(1.0  0.2 AUs, P < 0.05), and O128:B12 (0.9  0.4 AUs,
P < 0.05) (Figure 4, A and B). Increased cleavage (relative
molecular mass Z 28,000) of IL-1b compared with PBS
(0.1  0 AUs) was observed after LPS O127:B8 (2.1  0.7
AUs, P < 0.01) and O128:B12 (1.7  1.0 AUs, P < 0.05)
treatments (Figure 4, A and C). In contrast to mRNA levels,
protein expression of COX-2 was unchanged with LPS
O111:B4 and O55:B5 compared with control (1.1  0.3
AUs), but decreased levels were detected in the myometrium
of those animals administered O127:B8 (0.7  0.1 AUs)
compared with O111:B4 (1.3  0.3 AUs, P < 0.05) or
O128:B12 (0.8 0.1 AUs) compared with O55:B5 (1.2 0.4
AUs, P < 0.05) (Figure 4, A and D). Levels of total CX43
remained similar in all treatment groups (Figure 4, A and E).
Characterization of AP-1 and NF-kB Activation in
Neonatal Brain in Response to Upper-Uterine Injection
of Differing E. coli LPS Serotypes
To investigate the potential mechanism of LPS-induced fetal
death observed with speciﬁc LPS serotype treatments, the
activation pattern of the proinﬂammatory transcription fac-
tors, AP-1, NF-kB, and CEBP/b, was assessed. Pup brains2396were harvested from pregnant mice 6 hours following
injection of PBS control or speciﬁc LPS serotype, and
Western blot analysis was used to assess phosphorylation of
the AP-1 subunit, p-c-jun, the NF-kB subunit, p-p65, and
the LIP and LAP isoforms of CEBP/b (Figure 5, AeC). No
change in the levels of p-c-jun or p-p65 was identiﬁed in
pup brain after LPS administration (Figure 5, A and B). The
CEBP/b isoforms LIP and LAP were not detected in pup
brain protein lysates (Figure 5A).
Effect of LPS Serotypes on Inﬂammatory Gene
Expression in the Neonatal Brain
Evidence suggests that activation of inﬂammatory pathways
in the neonatal brains is the primary cause of neonatal brain
injury in the context of PTL.32,33 By using real-time quan-
titative RT-PCR, we explored the gene expression pattern of
inﬂammatory cytokines (Il-6, Il-8, Il-1b and Tnf-a mRNA)
whose exacerbated expression in neonatal brain during the
gestational period has been implicated in the development
of fetal inﬂammatory response syndrome, leading to a broad
spectrum of neurodevelopmental disorders after birth.34
Additional neuronal markers for brain damage, including
glial ﬁbrillary acidic protein (Gfap mRNA) and myelin
proteolipid protein (Plp mRNA), as well as inducible nitric
oxide synthase (iNOS) and endothelial Nos (Nos3), were
assessed. LPS O111:B4 treatment caused a signiﬁcant
increase in Il-8 mRNA levels in the neonatal brain
compared with control (6.6-fold change, P < 0.01), andajp.amjpathol.org - The American Journal of Pathology
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Figure 5 Levels of activated activator protein 1 and NF-kB remain largely unchanged in neonatal brain in response to upper-uterine injection of lipo-
polysaccharide (LPS) serotype. Whole neonatal brain tissue extracts, collected 6 hours after intrauterine injection of either phosphate-buffered saline (PBS) or
LPS serotypes O111:B4, O55:B5, O127:B8, or O128:B12, were assessed by Western blot analysis for p-c-Jun (A and B) and p-p65 (A and C). No changes in
inﬂammatory transcription factor activation in response to PBS or LPS administration are observed at 6 hours after treatment. Densitometric analysis of
immune-reactive bands was performed relative to b-actin (one-way analysis of variance with Tukey’s post hoc test). n Z 5 (AeC). AU, arbitrary unit; CAL,
calibrator; C/EBP, CCAAT/enhancer-binding protein; Ctrl, control; LAP, liver-enriched activator protein; LIP, liver-enriched inhibitory protein.
LPS Serotypes in Murine Preterm Laborthis increase was also signiﬁcantly higher compared with
O128:B12 treatment (4.1-fold change, P < 0.01)
(Figure 6A).
No signiﬁcant changes were detected in the levels of Il-6,
Tnf-a, and Il-1b mRNA after LPS treatment (Figure 6,
BeD). Maternal LPS administration did not alter expression
of any of the assessed brain damage markers in the neonatal
brains (Figure 6, EeH). Similar results were observed in
samples collected from pups isolated 4 hours after LPS
O111:B4 intrauterine injection, where only IL-1b was
signiﬁcantly increased compared with PBS (3-fold change,
P < 0.05), before any fetal demise being observed
(Supplemental Figure S1). Efforts were made to assess
protein levels of both full-length and cleaved IL-1b in pup
brain protein extracts; however, immune-reactive protein
was not detected (Supplemental Figure S2).Discussion
LPS Serotype Structure, Function, and Route of
Administration
In this study, we investigated the effects of four different
E. coli LPS serotypes (O111:B4, O55:B5, O127:B8, and
O128:B12) in a murine model of infection- and inﬂammation-
induced PTL. Intrauterine injection was selected as the route of
administration because it best mimics the most observed
clinical scenario of decidua/myometrial infection, which is
responsible for 25% to 40% of all preterm births.35,36 We
speciﬁcally chose LPS puriﬁed from E. coli because it is the
most frequently used LPS isolate in the context of infection-
and inﬂammation-induced preterm birth models, and because
colonization of the maternal vaginal ﬂora and urinary tract by
E. coli is associated with increased rate of PTL and poor
pregnancy outcomes.37,38 Furthermore, E. coli is the bacteriaThe American Journal of Pathology - ajp.amjpathol.orgmost frequently isolated from neonates who develop sepsis or
meningitis postpartum.39
Our data clearly show that, although all serotypes tested
lead to PTL, latency between time of injection and onset of
labor markedly varied between serotypes administered.
These data suggest that subtle changes in the sugar compo-
sition of the O-antigen possess the ability to differentially
activate functional pathways that precede myometrial acti-
vation and labor onset. Detection of LPS fromGram-negative
bacteria, such as E. coli, is achieved primarily through its
interaction with TLR4, which is expressed in the myome-
trium and other gestational tissues.21,40 Bäckhed et al41 have
previously shown a contribution of LPS substructures to its
endotoxic properties, indicating that the polysaccharide
O-antigen element may interfere with lipid A recognition by
the TLR4 receptor complex. Structural variances in the O-
antigen may thus change the interaction of LPS molecules
with the TLR4 receptor complex, possibly resulting in dif-
ferential activation of downstream inﬂammatory pathways.
Evidence for this includes the acquisition of bacterial im-
mune evasion properties through modulation of O-antigen
composition that alters macrophage recognition and phago-
cytosis of LPS molecules.42,43Impact of LPS Serotype on Maternal and Fetal Outcome
Our data show the existence of a relationship between latency
from LPS injection to labor onset and pup survival rates. LPS
O111:B4 induced the most rapid PTL onset (7 hours p.i.) and
was accompanied by 100% fetal death at 6 hours after
administration. In contrast, animals injected with LPS
O128:B12 delivered 17 hours p.i. with 100% pup survival.
Similar rates of infection- and inﬂammation-induced preterm
birth are achieved in mice when administered 25 mg per
mouse LPS O111:B4 i.p. on either E16 or E17.18 Yet, in this2397
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Figure 6 Effect of different lipopolysaccharide (LPS) serotypes on inﬂammatory gene expression in the fetal brain tissue. Expression of the mRNA of
inﬂammatory genes, Il-8 (A), Il-6 (B), Il-1b (C) Tnf-a (D), neutropic factors including glial ﬁbrillary acidic protein (Gfap E), proteolipid protein (Plp F),
inducible nitric oxide synthase (iNOS; G), and endothelial Nos (Nos3; H), was assessed by real-time quantitative RT-PCR in fetal brain tissue collected 6 hours
after surgery from mice injected with either phosphate-buffered saline (PBS) or LPS (serotypes O111:B4, O55:B5, O127:B8, or O128:B12). Data are presented
relative to b-actin mRNA levels. n Z 5 (AeH). *P < 0.05, **P < 0.01 (one-way analysis of variance with Tukey’s post hoc test).
Migale et almodel, pup survival rates are reduced from 58% at E17 to
39% at E16, suggesting a correlation between gestational age
and survival rate. In our study, pup survival rates were
consistently assessed on E16, precisely 6 hours after LPS
administration, and show that despite sharing the same
gestational age, offspring were differentially susceptible to
intrauterine fetal death, depending on the serotypes used to
induce PTL. These data indicate that fetal death is inﬂuenced
by LPS serotype and should be considered when designing
studies aimed to investigate fetal outcome in the context of
infection- and inﬂammation-induced PTL.
LPS Serotypes Differentially Activate Uterine
Inﬂammatory Pathways
To gain a better understanding of the potential mechanisms
underlying the observed maternal response to LPS serotype,
we examined the activation of key inﬂammatory transcrip-
tion factors known to regulate inﬂammatory and contractile
pathways in the myometrium at the time of labor onset. We
demonstrated that latency to labor after LPS injection2398correlates with the degree of AP-1 activation, but there is no
activation of NF-kB or C/EBPb. This is consistent with our
recent ﬁndings showing that murine PTL induced by intra-
uterine injection of LPS serotype O111:B4 is characterized
by AP-1 activation and does not require NF-kB activation.9
Our data, therefore, provide further evidence that AP-1
activation is a critical regulator of the terminal pathways or
labor onset. However, inﬂammatory transcription factor
activation varied greatly between LPS-serotype treatment, as
did downstream activation of associated inﬂammatory and
contraction genes and proteins. For example, LPS O111:B4
treatment led to the most rapid and potent stimulation of AP-1
and, consequently, the most robust stimulation of Tnf-a, Il-6,
Il-8, and Mmp10 mRNA. Although substantially less AP-1
activation was observed in the myometrium collected from
LPS O127:B8 treated animals, robust increases in mRNA
levels of Tnf-a, Il-6, Il-8, and Mmp10, as well as Cx-43 and
Mmp3, were detected at 6 hours p.i. These results allude to
differences in transcriptional regulation of inﬂammatory
pathway activation induced by the different LPS serotypes.
These differences appear to extend to protranslationalajp.amjpathol.org - The American Journal of Pathology
LPS Serotypes in Murine Preterm Laborregulation of proteins involved in contractility and inﬂam-
mation. For example, although comparable levels of Il-1b
mRNA were observed between LPS treatments, signiﬁcant
differences in the levels of proeIL-1b and cleaved IL-1b
were identiﬁed. Protein expression levels of the proin-
ﬂammatory cytokine IL-1b were signiﬁcantly increased by
LPS O111:B4 treatment. IL-1b is synthetized as a precursor
of 31 kDa that undergoes cleavage after activation of the
inﬂammasome complex.44 The inﬂammasome activation
yields the production of a 28-kDa intermediate product that is
retained in the cells longer than the mature form and can be
detected to infer the production and secretion of the mature
IL-1b peptide (17 kDa).45 It is currently unclear whether
these differences represent differing degrees of serotype-
speciﬁc stimulation of common molecular pathways
involved in myometrial contractility and inﬂammatory
response or serotype-speciﬁc activation of unique pathways.
Production of downstream inﬂammatory mediators, such as
IL-1b, TNFa, and COX-2, by speciﬁc LPS serotypes could
potentiate the inﬂammatory response via a positive feedback
mechanism that could partly account for the maternal and
neonatal phenotypic differences observed in this study.
Although detailed characterization of the relative contribu-
tion of these mediators to inﬂammatory pathway activation is
important, our data nevertheless show that different LPS
serotypes differentially modulate TLR4-mediated inﬂam-
matory activation and provide evidence that a proportion of
the reported variability in preterm birth and pup survival rates
in murine models can be attributed to LPS serotype.46e48
Impact of LPS Serotypes on Pup Survival and Neonatal
Brain Inﬂammation
Activation of inﬂammation in the neonatal brain and sub-
sequent production of inﬂammatory cytokines, such as
IL-1b and TNF-a, are correlated with adverse neonatal
outcome in premature newborns.33 By using an intrauterine
injection of LPS to induce preterm birth in the mouse,
Elovitz et al12 previously reported activation of type 1/type
2 helper T-cell cytokines and inﬂammatory markers in the
fetal pup brain 6 hours after injection using a high dose of
250 mg LPS O55:B5.14 A low-dose intrauterine injection of
50 mg LPS O55:B5 results in a modest increase of inﬂam-
matory mRNA markers in the pup brain 7 days after de-
livery. The comparatively low dose of LPS used in our
study to induce preterm birth may partly explain the lack of
observable differences in levels of phosphorylated NF-kB
and AP-1 in pup brain extracts at 6 hours after injection of
20 mg LPS O111:B4 and increase in one (Il-8 mRNA) of the
eight inﬂammatory and brain injury markers assessed in the
pup brain. It is possible that activation of inﬂammatory
transcription factors in the pup brain occurs before the 6-
hour sampling time point examined in this study. We have
recently shown that myometrial activation of AP-1 after
LPS O111:B4 occurs as early as 1 hour after injection.9 The
onset of PTL 7 hours after injection of LPS O111:B4 mayThe American Journal of Pathology - ajp.amjpathol.orgnot be a sufﬁciently long enough time to permit develop-
ment of a detectable inﬂammatory response in the fetal
brain. Conversely, it is possible that pup brain inﬂammation
may be detectable in animals treated with LPS O55:B5,
O127:B8, or O128:B12 at later stages after injection.
Regardless, the marked difference in fetal loss rates between
LPS serotypes has important signiﬁcance for studies using
LPS as a model of neonatal brain inﬂammation and injury.
It has been proposed that intrauterine fetal death in
response to LPS treatment may occur because of maternal
factors that inﬂuence susceptibility to LPS and efﬁciency of
LPS migration through the placenta to the fetus.49 Mater-
nally produced inﬂammatory mediators may then cross the
placenta to the fetus and elicit Fas-mediated apoptosis of
placental cells.50 This may provide a potential mechanism
for the increased Il-8 mRNA levels observed in the pup
brain and the difference in neonatal outcomes observed in
our study in the absence of any inﬂammatory transcription
activation.
Clinical Relevance of LPS Serotype-Speciﬁc
Inﬂammatory Responses in Preterm Birth
Our ﬁndings that E. coliederived LPS serotypes elicit
speciﬁc activation of TLR4-mediated inﬂammatory activa-
tion in the pregnant host and neonate may be of important
clinical relevance. Bacterial serotypes represent different
variations within species that are classiﬁed primarily
because of surface antigen properties. Subspecies classiﬁ-
cation of bacteria on the basis of serotype has long been
recognized as an important determinate of clinical outcome.
For example, group B streptococci (Streptococcus aga-
lactiae) are recognized as the leading cause of serious
bacterial infections in neonates.51,52 A difference in group B
streptococci virulence is associated with production of
serotype-speciﬁc capsular polysaccharide, which inhibits
deposition of host complement factor C3b and subsequent
opsonophagocytosis.53 Similarly, pneumococcal isolates of
serotypes 1 and 5 are associated with invasive disease,
whereas serotypes 6B and 23F are associated with car-
riage.54,55 In identifying and characterizing major differen-
tial effects induced by four E.coli serotypes, our data
provide evidence that subspecies of bacteria are likely to
induce different innate immune response patterns in vivo.
Such ﬁndings are important considerations for the future
design of therapeutics aimed to inhibit speciﬁc bacteria-
induced inﬂammatory pathway activation as a strategy to
prevent preterm birth and associated neonatal brain damage.Conclusion
In conclusion, we provide evidence that speciﬁc LPS sero-
types induce differential activation of inﬂammatory tran-
scription factors as well as downstream contractile and
inﬂammatory pathways in both the myometrium and2399
Migale et alneonatal pup brain. Although these data may provide
important information that can account, in part, for reported
differences in murine models of infection- and
inﬂammation-induced PTL, they also indicate that the use of
selective LPS serotypes may provide a useful tool for tar-
geting and exploring speciﬁc inﬂammatory response
mechanisms in mouse models of preterm birth.
Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2015.05.015.
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